Association between Cognitive Impairment and Hippocampal Subfield Volumes in Multiple System Atrophy

Atsuhiko Sugiyama1, Hajime Yokota2, Shigeki Hirano1

  • 1Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Parkinson'S Disease
|March 16, 2023
PubMed

Insights

Multiple system atrophy (MSA) patients with cognitive impairment show reduced right cornu ammonis (CA) 2/3 volume. These hippocampal changes correlate with cognitive function, suggesting structural alterations contribute to cognitive deficits in MSA.

Area of Science:

  • Neuroimaging
  • Neurodegeneration
  • Cognitive Neuroscience

Background:

  • Multiple system atrophy (MSA) is a progressive neurodegenerative disorder.
  • Cognitive impairment is a common feature in MSA, affecting various domains.
  • Understanding the underlying structural changes in the brain is crucial for managing MSA.

Purpose of the Study:

  • To investigate hippocampal subfield morphological changes in patients with MSA.
  • To differentiate these changes between MSA with cognitive impairment (MSA-CI) and MSA with cognitive preservation (MSA-CP).
  • To explore the relationship between hippocampal subfield volumes and cognitive function in MSA.

Main Methods:

  • Utilized FreeSurfer-automated segmentation for hippocampal subfield volumetry.
  • Analyzed 75 patients with MSA (40 MSA-CI, 35 MSA-CP) and 68 healthy controls.
  • Performed regression analyses to correlate subfield volumes with cognitive scores.

Main Results:

  • MSA-CI patients exhibited significantly lower right cornu ammonis (CA) 2/3 volume compared to controls.
  • MSA-CP patients showed a significantly higher left fimbria volume than controls.
  • Right CA2/3 volume positively correlated with Frontal Assessment Battery scores in MSA patients.

Conclusions:

  • Hippocampal subfield volume reduction occurs in MSA-CI, even in early stages.
  • Specific hippocampal structural alterations are linked to cognitive deficits in MSA.
  • These findings highlight the hippocampus's role in MSA-related cognitive dysfunction.